DNAJC10 / ERDJ5 antibody
Principal name
DNAJC10 / ERDJ5 antibody
Alternative names for DNAJC10 / ERDJ5 antibody
Macrothioredoxin, DnaJ homolog subfamily C member 10, ER-resident protein ERdj5
Ncbi ID
9606, NP_061854, ADR83402.1, NP_061854.1, NP_077143.2, NM_001106486, NM_018981
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Immunocytochemistry/Immunofluorescence (ICC/IF), Western blot / Immunoblot (WB), Paraffin Sections (P)
Background of DNAJC10 / ERDJ5 antibody
- Kit Component:
- - KN304678G1, Dnajc10 gRNA vector 1 in pCas-Guide vector
- KN304678G2, Dnajc10 gRNA vector 2 in pCas-Guide vector
- KN304678D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunoperoxidase of monoclonal antibody to DNAJC10 on formalin-fixed paraffin-embedded human stomach. [antibody concentration 3 ug/ml]
Immunofluorescence of monoclonal antibody to DNAJC10 on HeLa cell. [antibody concentration 10 ug/ml]
DNAJC10 monoclonal antibody (M01), clone 3C4. Western Blot analysis of DNAJC10 expression in HeLa ( Cat # L013V1 ).
DNAJC10 monoclonal antibody (M01), clone 3C4. Western Blot analysis of DNAJC10 expression in NIH/3T3 ( Cat # L018V1 ).
DNAJC10 monoclonal antibody (M01), clone 3C4. Western Blot analysis of DNAJC10 expression in Raw 264.7 ( Cat # L024V1 ).
DNAJC10 monoclonal antibody (M01), clone 3C4. Western Blot analysis of DNAJC10 expression in PC-12 ( Cat # L012V1 ).
Detection limit for recombinant GST tagged DNAJC10 is approximately 10ng/ml as a capture antibody.
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in human kidney.
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in NIH/3T3 ( Cat # L018V1 ).
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in Raw 264.7 ( Cat # L024V1 ).
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in PC-12 ( Cat # L012V1 ).
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in HeLa ( Cat # L013V1 ).
DNAJC10 monoclonal antibody (M01), clone 3C4. Western Blot analysis of DNAJC10 expression in NIH/3T3 ( Cat # L018V1 ).
DNAJC10 monoclonal antibody (M01), clone 3C4. Western Blot analysis of DNAJC10 expression in Raw 264.7 ( Cat # L024V1 ).
DNAJC10 monoclonal antibody (M01), clone 3C4. Western Blot analysis of DNAJC10 expression in PC-12 ( Cat # L012V1 ).
DNAJC10 monoclonal antibody (M01), clone 3C4. Western Blot analysis of DNAJC10 expression in HeLa ( Cat # L013V1 ).
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in human kidney.
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in NIH/3T3 ( Cat # L018V1 ).
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in Raw 264.7 ( Cat # L024V1 ).
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in PC-12 ( Cat # L012V1 ).
DNAJC10 monoclonal antibody (M02), clone 3A8. Western Blot analysis of DNAJC10 expression in HeLa ( Cat # L013V1 ).
Human ACHN; WB Suggested Anti-DNAJC10 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:2500. Positive Control: ACHN cell lysate. DNAJC10 is strongly supported by BioGPS gene expression data to be expressed in Human ACHN cells.; DNAJC10 antibody - N-terminal region (ARP49418_P050) in Human ACHN cells using Western Blot
Predicted cell location: Cytoplasm . Positive control: Human colon and cervical cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human colon cancer tissue using DNAJC10 antibody at dilution 1/15, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm . Positive control: Human colon and cervical cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human cervical cancer tissue using DNAJC10 antibody at dilution 1/15, on the right is treated with the fusion protein. (Original magnification:x200)
Predicted cell location: Cytoplasm . Positive control: Human thyroid and ovarian cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human thyroid cancer tissue using DNAJC10 antibody at dilution 1/20, on the right is treated with the fusion protein. (Original magnification:x 200)
Predicted cell location: Cytoplasm . Positive control: Human thyroid and ovarian cancer tissue. Recommended dilution: 1/25-100 The image on the left is immunohistochemistry of paraffin-embedded human ovarian cancer tissue using DNAJC10 antibody at dilution 1/20, on the right is treated with the fusion protein. (Original magnification:x200)
WB Suggested Anti-DNAJC10 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1:2500; Positive Control: ACHN cell lysate; DNAJC10 is strongly supported by BioGPS gene expression data to be expressed in Human ACHN cells
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA331073 | DNAJC10 / ERDJ5 antibody |
||||||
| Rabbit polyclonal Anti-DNAJC10 Antibody | |||||||
 |
Rabbit | IgG | Purified | Bov, Can, Eq, GP, Hu, Ms, Rb, Rt, Ze | WB |
50 µg /
$360.00
|
|
| OriGene Technologies, Inc. | |||||||